Abstract
THYROTROPIN-RELEASING hormone (TRH) has been shown to produce marked changes in the central nervous system unrelated to its actions on the anterior pituitary which result in the release of thyrotropin and prolactin1. The first evidence for central effects of TRH were provided by observations that TRH potentiated L-dihydroxyphenylalanine-induced excitation in pargyline pretreated, hypophysectomised animals2. Subsequently, TRH was found to antagonise the sedative and hypothermie effects of ethanol and pento-barbital3–5. These results of TRH administration may depend upon many factors, including dose, time after administration and presence of other pharmacological agents, as well as on the parameters being measured. Although the effects of TRH have been shown to be extra-pituitary in nature5, biochemical and neural mechanisms that might account for its pharmacological actions have not been elucidated. Redos et al.6 recently reported that ethanol causes a dose-dependent decline in cerebellar guanosine-3′,5′-monophosphate (cGMP) without significantly altering adenosine-3′,5′-monophosphate (cAMP). As blood ethanol content inversely paralleled cGMP levels, they postulated that the ataxia produced by ethanol may be due to alterations in cGMP in the cerebellum. Though these changes may also reflect a feedback mechanism in response to the drug, it was of some interest to determine if these ethanol actions on cGMP were affected by TRH. We report here that decreases in cerebellar cGMP induced by ethanol are antagonised by administration of TRH and that administration of TRH itself results in significant elevation in cerebellar cGMP. These alterations in cerebellar cGMP provide the first biochemical evidence of non-hormonal actions of this tripeptide.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bowers, C. Y., Friesen, H. G., Hwang, D., Guyda, H. J. & Folkers, K. Biochem. biophys. Res. Commun. 45, 1003 (1971).
Plotnikoff, N. P., Prange, A. J., Breese, G. R., Anderson, M. S. & Wilson, I. C. Science 178, 417 (1972).
Breese, G. R., Cott, J. M., Cooper, B. R., Prange, A. J. & Lipton, M. A. Life Sci. 140, 1053 (1974).
Breese, G. R. et al. J. Pharmac. exp. Ther. 193, 11 (1975).
Cott, J. M., Breese, G. R., Cooper, B. R., Barlow, T. S. & Prange, A. J. J. Pharmac. exp. Ther. 196, 594 (1976).
Redos, J. D., Catravas, G. N. & Hunt, W. A. Science 193, 58 (1976).
Steiner, A. L., Wehmann, R. E., Parker, C. W. & Kipnis, D. M. Adv. Cyclic Nucleotide Res. 2, 51 (1972).
Bassiri, R. M. & Utiger, R. D. Endocrinology 90, 722 (1971).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265 (1951).
Volicer, L. & Gold, B. I. Life Sci. 13, 269 (1973).
Redos, J. D., Hunt, W. A. & Catravas, G. N. Life Sci. 18, 989 (1976).
Biggio, G., Costa, E. & Guidotti, A. J. Pharmac. exp. Ther. 200, 207 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MAILMAN, R., FRYE, G., MUELLER, R. et al. Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP. Nature 272, 832–833 (1978). https://doi.org/10.1038/272832a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/272832a0
This article is cited by
-
Thyrotropin-releasing hormone (TRH) in the cerebellum
The Cerebellum (2008)
-
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function
Psychopharmacology (1980)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.